By JUDY SIEGEL
Read the full story at the Jerusalem Post
12/19/2011 06:42

Heart attack, stroke treatment to benefit from Israeli breakthrough.

Embryonic Stem Cells. Prof. Joseph Itskovitz-Eldor was co-author of the groundbreaking paper announcing their first cultivation… since then Technion has become a global leader in stem-cell research & tissue engineering to harness the promise of this discovery.

Researchers at the Technion- Israel Institute of Technology and Rambam Medical Center in Haifa are the first in the world to create new blood vessels using embryonic stem cells that were programmed in advance.

The breakthrough cells were cultured in the lab in large amounts – enough to use them for treating cardiovascular diseases in patients.

The team was headed by Prof. Joseph Itskovitz- Eldor, head of the obstetrics/ gynecology department at Rambam and the stem cell lab at the Technion’s Rappaport Faculty of Medicine, together with Dr. Ayelet Dar-Vaknin. An article was published online in the journal Circulation over the weekend.

The research team produced cells called pericytes, which are needed to build blood vessels and to ensure their function.

They were produced during the differentiation of embryonic stem cells using markers characteristic of cell membranes.

When they were injected into mice leg muscles whose blood vessels had been almost fully blocked, the pericytes created new blood vessels and rehabilitated the muscle cells that had been harmed by the inadequate supply of oxygen.

The experiment is equivalent to treatment on harm to other vessels starved for oxygen such as after heart attacks and strokes.

The pericytes were produced from embryos whose source was fertilized eggs donated for research and from adult stem cells.

The stem cells were reprogrammed using genetic manipulations to have characteristics of embryonic stem cells, which can produce any kind of body cells. Since they can be produced from the patient himself, the pericytes are not rejected by the patient’s immune system.

Full story at JPost.com

You can follow the Technion Lokey Center for Life Science & Engineering on Facebook and Twitter!